James Matera, DO, explains the interaction between diabetes, cardiovascular disease, and kidney disease, and how the presence of one or more of these conditions can complicate treatment outcomes.
Mary Ann Hodorowicz, RDN, CDE, gives a preview of her upcoming Cardiometabolic Risk Summit talk on what clinicians can do to provide high-quality outpatient services related to cardiometabolic health, as...
Mary Ann Hodorowicz, RDN, CDE, gives a preview of her upcoming Cardiometabolic Risk Summit talk on what clinicians can do to provide high-quality outpatient services related to cardiometabolic health, as...
In his session at this year's Cardiometabolic Risk Summit, Dr Grumet discusses how sharing your story with patients via social media and other avenues can help bridge the intimacy gap.
In this podcast, Robert P. Giugliano, MD, discusses the safety and efficacy findings from IMPROVE-IT, the practical implications for ezetimibe, and more.
She talks about evaluating obesity medications, her tips for choosing the right medication for the right patient, and medications that are on the horizon. This is also the topic of her session at our...
In this podcast, Dr Bruce Lee from the Global Obesity Prevention Center at Johns Hopkins talks about the many contributing factors to childhood obesity as well as possible solutions to the growing...
In this podcast, Peter Reaven, MD, discusses the effects of glucose variability on vascular disease outcomes, the results of the ACCORD and VADT trials, and how the trials' results have impacted clinical...
Stephanie Chung, MBBS, from the National Institutes of Health, answers our questions about her research on a 1-hour glucose tolerance test for diagnosing diabetes in teenaged girls.
Deborah B. Horn, DO, MPH, from the University of Texas McGovern Medical School, talks about physical activity monitoring using fitness trackers, how to personalize each individual patient's...
